Total-Body Positron Emission Tomography (PET) Imaging Market Report 2026

Total-Body Positron Emission Tomography (PET) Imaging Market Overview

• Total-Body Positron Emission Tomography (PET) Imaging market size has reached to $1.4 billion in 2025 • Expected to grow to $2.63 billion in 2030 at a compound annual growth rate (CAGR) of 13.5% • Growth Driver: Rising Cancer Incidence Driving Demand For The Market Due To Increasing Need For Early And Accurate Cancer Detection • Market Trend: Advancements In Whole-Body Molecular Imaging For Faster And More Accurate Disease Detection • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Total-Body Positron Emission Tomography (PET) Imaging Market?

Total-body positron emission tomography (PET) imaging is an advanced nuclear medicine technique that captures metabolic and physiological activity across the entire human body in a single scan. It uses radiotracers to detect gamma rays emitted from positron decay, enabling highly sensitive visualization of biological processes. It offers significantly improved speed, image quality, and diagnostic accuracy due to its extended field of view and higher detection efficiency. The main components of total-body positron emission tomography (PET) imaging include systems, detectors, software, and services. Systems refer to the integrated PET imaging platforms used to capture and reconstruct high-resolution whole-body functional images for clinical and research purposes. These systems are built using detector types such as scintillator crystals, semiconductor detectors, and other detector types. They are used in applications including oncology, cardiology, neurology, research, and others, are utilized by end users including hospitals, diagnostic imaging centers, research institutes, and others.

What Is The Total-Body Positron Emission Tomography (PET) Imaging Market Growth Forecast?

The total-body positron emission tomography (PET) imaging market size is expected to see rapid growth in the next few years. It will grow to $2.63 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to rising demand for precision oncology and personalized medicine, increasing adoption of ai driven diagnostic imaging workflows, growth in early disease detection and preventive healthcare screening, expansion of research in molecular imaging and drug development, rising investment in advanced hospital imaging infrastructure. Major trends in the forecast period include increasing adoption of ai-assisted pet image reconstruction and interpretation, rising demand for total body pet systems with ultra wide field of view imaging, growing use of semiconductor based detectors for higher sensitivity and resolution, expansion of hybrid pet-ct and pet-mri diagnostic platforms, increasing integration of cloud based imaging data storage and analysis solutions.

Global Total-Body Positron Emission Tomography (PET) Imaging Market Segmentation

1) By Component: Systems, Detectors, Software, Services 2) By Detector Type: Scintillator Crystals, Semiconductor Detectors, Other Detector Types 3) By Application: Oncology, Cardiology, Neurology, Research, Other Applications 4) By End User: Hospitals, Diagnostic Imaging Centers, Research Institutes, Other End Users Subsegments: 1) By Systems: Standalone Positron Emission Tomography Systems, Hybrid Positron Emission Tomography And Computed Tomography Systems, Positron Emission Tomography And Magnetic Resonance Imaging Systems 2) By Detectors: Lutetium Yttrium Orthosilicate Detectors, Lutetium Oxyorthosilicate Detectors, Bismuth Germanate Detectors 3) By Software: Image Reconstruction Software, Quantification And Analysis Software, Artificial Intelligence Based Imaging Software 4) By Services: Installation And Integration Services, Maintenance And Repair Services, Calibration Services

What Is The Driver Of The Total-Body Positron Emission Tomography (PET) Imaging Market?

The increasing prevalence of cancer is expected to propel the growth of the total-body positron emission tomography (PET) imaging market going forward. Cancer is a disease caused by uncontrolled growth of abnormal cells that can invade and damage surrounding tissues and spread throughout the body. Cancer is increasing partly due to rising exposure to risk factors such as tobacco, pollution, and unhealthy lifestyles, which damage cells and increase the chance of uncontrolled growth. Total-body positron emission tomography (PET) imaging helps with cancer by providing a complete whole-body scan in one session that detects cancerous activity early, identifies metastasis more precisely, and helps doctors monitor treatment effectiveness with higher accuracy and speed. For instance, in May 2023, according to the Melanoma Focus, a UK-based national charity, by 2038, the UK could see approximately 26,500 new melanoma skin cancer cases annually, up from the current 16,700. Therefore, the increasing prevalence of cancer is driving the growth of the total-body positron emission tomography (PET) imaging industry.

Key Players In The Global Total-Body Positron Emission Tomography (PET) Imaging Market

Major companies operating in the total-body positron emission tomography (pet) imaging market are Siemens Healthineers AG, GE HealthCare Technologies Inc., Shanghai United Imaging Healthcare Co. Ltd., Koninklijke Philips N.V., Canon Medical Systems Corporation, Bruker Corporation, Mediso Medical Imaging Systems Ltd., MILabs B.V., MR Solutions Ltd., PETsys Electronics S.A., NorthStar Medical Radioisotopes

Global Total-Body Positron Emission Tomography (PET) Imaging Market Trends and Insights

Major companies operating in the total-body positron emission tomography (PET) imaging market are focusing on developing innovative solutions, such as a whole-body molecular imaging system, to enhance diagnostic accuracy, enable faster scanning, and improve early disease detection across the entire body in a single scan. A whole-body molecular imaging system is an advanced medical imaging technology that captures detailed images of biological and metabolic processes throughout the entire body simultaneously, helping detect diseases such as cancer, neurological disorders, and cardiovascular conditions at an early stage. For instance, in December 2024, the UK government unveiled a new total body PET (positron emission tomography) scanner, designed to image a patient’s entire body in one scan, with much higher sensitivity and faster speed than conventional PET, enabling earlier detection of cancer, dementia, and other diseases while using lower radiation doses.

What Are Latest Mergers And Acquisitions In The Total-Body Positron Emission Tomography (PET) Imaging Market?

In June 2025, GE HealthCare, a US-based medical technology company, partnered with Stanford Medicine to advance total-body positron emission tomography (PET) or computed tomography (CT) technology for improving diagnostic imaging, accelerating scan efficiency, and enhancing clinical research capabilities. This partnership aims to accelerate innovation in total-body PET or CT imaging to improve early disease detection, optimize patient care, and expand precision medicine research applications. Stanford Medicine is a US-based academic health system.

Regional Outlook

North America was the largest region in the total-body positron emission tomography (PET) imaging market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Total-Body Positron Emission Tomography (PET) Imaging Market?

The total-body positron emission tomography (PET) imaging market consists of revenues earned by entities by providing services such as whole-body metabolic imaging, clinical research and drug development support, and quantitative imaging and data analytics. The market value includes the value of related goods sold by the service provider or included within the service offering. The total-body positron emission tomography (PET) The imaging market also includes sales of digital PET detector modules, time-of-flight (TOF) PET imaging systems, and radiopharmaceutical imaging solution integration systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Total-Body Positron Emission Tomography (PET) Imaging Market Report 2026?

The total-body positron emission tomography (PET) imaging market research report is one of a series of new reports from The Business Research Company that provides total-body positron emission tomography (PET) imaging market statistics, including total-body positron emission tomography (PET) imaging industry global market size, regional shares, competitors with a total-body positron emission tomography (PET) imaging market share, detailed total-body positron emission tomography (PET) imaging market segments, market trends and opportunities, and any further data you may need to thrive in the total-body positron emission tomography (PET) imaging industry. This total-body positron emission tomography (PET) imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.